Bayer HealthCare introduces eight-month flea, tick collar
SHAWNEE, Kan. — Bayer HealthCare has introduced a product for controlling fleas and ticks in dogs and cats that lasts eight months, the company’s animal health division said Thursday.
Seresto is a collar that is designed to provide protection from parasites similar to that provided by monthly topical medications. The collar’s active ingredients are flumethrin and imidacloprid, and the company said it kills fleas within 24 hours and ticks within 48 hours after application.
"No other flea or tick preventive provides eight months of effective flea and tick protection with only one application for both dogs or cats," Bayer HealthCare animal health division president and general manager Ian Spinks said. "Bayer HealthCare Animal Health wants to be the go-to company for parasiticide solutions. With Seresto, we give pet owners a new alternative to spot-on topical flea and tick and oral flea prevention."
Beiersdorf off to ‘good start’ for 2013
HAMBURG, Germany — Skin care brand Beiersdorf announced on Thursday that it has “continued last year’s positive trend in the first quarter of 2013.”
Organic group sales rose by 5.4%, and nominal sales increased by 2.9%, from €1,533 million to €1,577 million. The key driver for this positive performance was the double-digit sales growth recorded in emerging markets, the company stated. Consolidated profit after tax rose to €155 million.
“Beiersdorf made a good start into the year 2013. We have made further progress in implementing our Blue Agenda, in particular in the areas of brands and innovation. Furthermore, we expanded our position and increased our market share in emerging markets,” stated Stefan F. Heidenreich, CEO of Beiersdorf AG.
Sales in North America were up 5.4% compared with the year-ago period.
The consumer business segment increased its sales organically by 5.7% in the first three months of fiscal year 2013. Nominal sales increased by 3.2%, from €1,277 million to €1,318 million.
Nivea recorded sales growth of 5.7% as against the prior-year quarter. Eucerin generated a 9.4% increase in sales as of the end of the period and La Prairie an 8.2% increase.
Novelis introduces 90% recycled aluminum can
ATLANTA — Novelis today announced the commercial availability of a high recycled-content aluminum designed specifically for the beverage can market.
With a minimum of 90% recycled aluminum, the Novelis Evercan aluminum beverage can body sheet will allow beverage companies to deliver soft drinks, beer and other popular beverages in a low-carbon footprint consumer package.
"We are excited to be able to deliver yet another tangible result of our commitment to sustainable aluminum product innovation," said Phil Martens, Novelis president and chief executive officer. "Our Novelis Evercan high-recycled content beverage can body sheet, backed by the industry’s first independent certification program, represents tremendous progress in sustainable consumer products packaging. As the world’s leading supplier of aluminum beverage can sheet, this is an important step toward delivering on our ultimate vision of an aluminum can with up to 100% recycled content."
The Evercan is the industry’s first independently certified, high-recycled content aluminum, the company stated.
Novelis Evercan aluminum sheet has been certified for high-recycled content by SCS Global Services, a trusted leader in third-party environmental, sustainability and food quality certification, auditing, testing and standards development. Novelis is initially offering aluminum can body sheet guaranteed to contain at least 90% recycled content. When combined with the can end made of a different alloy during the can making process, the new Novelis Evercan will enable beverage companies to market their beverages in standard 12-oz. aluminum cans certified as made from a minimum of 70% recycled content. The Novelis Evercan aluminum beverage can body sheet is commercially available now in North America and Europe and will be available worldwide later this year.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.